W.G. Shaheen & Associates Dba Whitney & CO Gilead Sciences, Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $3.57 Million - $3.9 Million	-56,251 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $79,080 - $90,230	1,318 Added 2.4%	56,251 $3.64 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $71,322 - $81,268	-1,259 Reduced 2.24%	54,933 $3.66 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $60,237 - $75,737	970 Added 1.76%	56,192 $3.55 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $208,917 - $242,592	2,888 Added 5.52%	55,222 $4.25 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $86,742 - $111,104	1,385 Added 2.72%	52,334 $3.91 Million
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $44,674 - $49,140	-725 Reduced 1.4%	50,949 $3.31 Million
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $139,647 - $154,146	2,234 Added 4.52%	51,674 $3.37 Million
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $32,791 - $36,771	530 Added 1.08%	49,440 $3.34 Million
Q1 2019 May 06, 2019	BUY	$62.53 - $70.05 $156,137 - $174,914	2,497 Added 5.38%	48,910 $3.18 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $214,493 - $279,897	-3,543 Reduced 7.09%	46,413 $3.25 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $157,600 - $174,492	2,211 Added 4.63%	49,956 $3.59 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $226,496 - $264,198	3,491 Added 7.89%	47,745 $3.38 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $246,709 - $300,765	3,387 Added 8.29%	44,254 $3.34 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $99,752 - $117,095	1,402 Added 3.55%	40,867 $2.93 Million
Q2 2017 Aug 11, 2017	BUY	N/A	39,465	39,465 $2.79 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.77 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.46 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.32 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account